HER2 MUTATIONS BREAST NEOPLASMS

Clinical trials for HER2 MUTATIONS BREAST NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HER2 MUTATIONS BREAST NEOPLASMS trials appear

Sign up with your email to follow new studies for HER2 MUTATIONS BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo targets Hard-to-Treat cancers in major trial

Disease control Ongoing

This study is testing whether the drugs tucatinib and trastuzumab can help control advanced solid tumors that have specific changes in a protein called HER2. It is for adults with cancers like lung, cervical, or uterine cancer that have spread or cannot be removed by surgery, and…

Matched conditions: HER2 MUTATIONS BREAST NEOPLASMS

Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

HER2 MUTATIONS BREAST NEOPLASMS

Get alerted when new HER2 MUTATIONS BREAST NEOPLASMS trials appear

New drug duo targets Hard-to-Treat cancers in major trial